Endothelial Cell CD36 Reduces Atherosclerosis and Controls Systemic Metabolism.
CD36
atherosclerosis
endothelium
fatty acid transport
metabolism
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
08
2021
accepted:
20
10
2021
entrez:
10
12
2021
pubmed:
11
12
2021
medline:
11
12
2021
Statut:
epublish
Résumé
High-fat Western diets contribute to tissue dysregulation of fatty acid and glucose intake, resulting in obesity and insulin resistance and their sequelae, including atherosclerosis. New therapies are desperately needed to interrupt this epidemic. The significant idea driving this research is that the understudied regulation of fatty acid entry into tissues at the endothelial cell (EC) interface can provide novel therapeutic targets that will greatly modify health outcomes and advance health-related knowledge. Dysfunctional endothelium, defined as activated, pro-inflammatory, and pro-thrombotic, is critical in atherosclerosis initiation, in modulating thrombotic events that could result in myocardial infarction and stroke, and is a hallmark of insulin resistance. Dyslipidemia from high-fat diets overwhelmingly contributes to the development of dysfunctional endothelium. CD36 acts as a receptor for pathological ligands generated by high-fat diets and in fatty acid uptake, and therefore, it may additionally contribute to EC dysfunction. We created EC CD36 knockout (CD36°) mice using cre-lox technology and a cre-promoter that does not eliminate CD36 in hematopoietic cells (Tie2e cre). These mice were studied on different diets, and crossed to the low density lipoprotein receptor (LDLR) knockout for atherosclerosis assessment. Our data show that EC CD36° and EC CD36°/LDLR° mice have metabolic changes suggestive of an uncompensated role for EC CD36 in fatty acid uptake. The mice lacking expression of EC CD36 had increased glucose clearance compared with controls when fed with multiple diets. EC CD36° male mice showed increased carbohydrate utilization and decreased energy expenditure by indirect calorimetry. Female EC CD36°/LDLR° mice have reduced atherosclerosis. Taken together, these data support a significant role for EC CD36 in systemic metabolism and reveal sex-specific impact on atherosclerosis and energy substrate use.
Identifiants
pubmed: 34888367
doi: 10.3389/fcvm.2021.768481
pmc: PMC8650007
doi:
Types de publication
Journal Article
Langues
eng
Pagination
768481Informations de copyright
Copyright © 2021 Rekhi, Omar, Alexiou, Delyea, Immaraj, Elahi and Febbraio.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Hum Mol Genet. 2008 Jun 1;17(11):1695-704
pubmed: 18305138
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):804-16
pubmed: 25705917
Am J Transl Res. 2020 Dec 15;12(12):7737-7761
pubmed: 33437358
Biochem Biophys Res Commun. 2000 Aug 28;275(2):446-54
pubmed: 10964685
Circulation. 2004 Mar 30;109(12):1550-7
pubmed: 15023869
Circ J. 2011;75(12):2722-30
pubmed: 22076424
Prostaglandins Leukot Essent Fatty Acids. 2006 Sep;75(3):149-59
pubmed: 16829065
Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2333-8
pubmed: 15486305
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2199-205
pubmed: 24947523
Diabetes. 2011 Apr;60(4):1100-10
pubmed: 21378177
J Nucl Med. 1998 Oct;39(10):1681-4
pubmed: 9776268
J Clin Invest. 2000 Apr;105(8):1095-108
pubmed: 10772654
Circ Res. 2007 Mar 16;100(5):712-20
pubmed: 17293482
J Biol Chem. 1990 Sep 25;265(27):16296-9
pubmed: 1697855
Nat Commun. 2020 Sep 21;11(1):4765
pubmed: 32958780
Curr Opin Lipidol. 2019 Oct;30(5):377-382
pubmed: 31348024
J Biol Chem. 2002 Oct 11;277(41):38517-23
pubmed: 12145296
Nat Immunol. 2010 Feb;11(2):155-61
pubmed: 20037584
Sci Transl Med. 2019 Feb 6;11(478):
pubmed: 30728288
J Mol Cell Cardiol. 2013 Oct;63:180-8
pubmed: 23948483
Biochem Biophys Res Commun. 1995 Feb 15;207(2):747-52
pubmed: 7864868
Front Physiol. 2020 Jan 29;10:1607
pubmed: 32063863
Cell Microbiol. 2007 Aug;9(8):2030-9
pubmed: 17419716
Cell Rep. 2019 Dec 10;29(11):3405-3420.e5
pubmed: 31825825
J Lipid Res. 2005 Oct;46(10):2175-81
pubmed: 16024917
PLoS One. 2015 May 04;10(5):e0125126
pubmed: 25938460
Can J Cardiol. 2012 Nov-Dec;28(6):631-41
pubmed: 22985787
Int J Obes (Lond). 2006 Jun;30(6):877-83
pubmed: 16418758
Theranostics. 2019 Jul 9;9(17):4893-4908
pubmed: 31410189
J Biol Chem. 1993 Jun 5;268(16):11811-6
pubmed: 7685021
J Biol Chem. 2012 Jul 6;287(28):23502-16
pubmed: 22584574
J Biol Chem. 2000 Oct 20;275(42):32523-9
pubmed: 10913136
Trends Endocrinol Metab. 2014 Feb;25(2):99-106
pubmed: 24315207
Cell Metab. 2018 Oct 2;28(4):656-666.e1
pubmed: 30017358
Sci Signal. 2009 May 26;2(72):re3
pubmed: 19471024
J Immunol. 1992 Jan 1;148(1):78-83
pubmed: 1370173
JCI Insight. 2021 Sep 8;6(17):
pubmed: 34314388
Circ Res. 2008 Jun 20;102(12):1512-9
pubmed: 18497330
Arch Oral Biol. 2021 Jun;126:105129
pubmed: 33934042
J Neurochem. 2011 May;117(4):735-46
pubmed: 21395585
J Exp Med. 2003 Nov 17;198(10):1517-25
pubmed: 14623907
Acta Physiol Scand. 2003 Aug;178(4):347-56
pubmed: 12864739
J Clin Invest. 2009 Jan;119(1):110-24
pubmed: 19065047
Nature. 2005 Feb 3;433(7025):523-7
pubmed: 15690042
Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2549-57
pubmed: 23968980
J Immunol. 2018 Jun 15;200(12):4044-4058
pubmed: 29735482
Prog Lipid Res. 2013 Oct;52(4):446-64
pubmed: 23774609
J Nucl Med. 1999 Feb;40(2):239-43
pubmed: 10025829
Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1740-9
pubmed: 17264223
J Biol Chem. 2011 Mar 4;286(9):7010-7
pubmed: 21209086
Cardiovasc Res. 2011 Feb 15;89(3):604-13
pubmed: 21088116
J Exp Med. 2014 May 5;211(5):887-907
pubmed: 24752299
J Exp Med. 2006 Nov 27;203(12):2613-25
pubmed: 17101731
Gastroenterology. 2008 Feb;134(2):556-67
pubmed: 18242221
Biochemistry. 2013 Oct 15;52(41):7254-61
pubmed: 24090054
Mol Cell Biochem. 2002 Oct;239(1-2):17-23
pubmed: 12479564
FASEB J. 2004 Jul;18(10):1144-6
pubmed: 15132977
Nat Commun. 2016 Sep 26;7:12837
pubmed: 27667267
J Clin Invest. 2002 May;109(10):1381-9
pubmed: 12021254
Nutr Res Rev. 2012 Dec;25(2):288-301
pubmed: 23174512
J Neurosci. 2005 Mar 9;25(10):2504-12
pubmed: 15758158
Am J Physiol Cell Physiol. 2009 Jun;296(6):C1329-37
pubmed: 19279231
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1481-7
pubmed: 19608973
Physiology (Bethesda). 2013 Mar;28(2):125-34
pubmed: 23455771
Nat Med. 2000 Jan;6(1):41-8
pubmed: 10613822
Blood. 2011 May 26;117(21):5744-50
pubmed: 21427288
J Clin Invest. 2000 Apr;105(8):1049-56
pubmed: 10772649
Nat Med. 2007 Sep;13(9):1086-95
pubmed: 17721545
Physiol Rev. 2010 Jan;90(1):367-417
pubmed: 20086080
J Biol Chem. 2007 Sep 14;282(37):27392-27401
pubmed: 17623670
J Clin Invest. 2009 Jan;119(1):136-45
pubmed: 19065049
Cell Metab. 2006 Sep;4(3):211-21
pubmed: 16950138
Mol Biol Cell. 2012 Aug;23(16):3057-68
pubmed: 22718904
Am J Physiol Lung Cell Mol Physiol. 2019 May 1;316(5):L740-L750
pubmed: 30702342
J Immunol. 2006 Sep 15;177(6):4047-54
pubmed: 16951368
J Biol Chem. 1999 Jul 2;274(27):19055-62
pubmed: 10383407
Free Radic Biol Med. 2021 May 20;168:180-188
pubmed: 33775772
Circ Res. 2021 Feb 5;128(3):433-450
pubmed: 33539224
J Mol Neurosci. 2001 Apr-Jun;16(2-3):99-108; discussion 151-7
pubmed: 11478390
J Biol Chem. 1993 Aug 25;268(24):17665-8
pubmed: 7688729
Annu Rev Nutr. 2014;34:281-303
pubmed: 24850384
Ann Biomed Eng. 2013 Jul;41(7):1411-27
pubmed: 23229281
J Clin Invest. 2018 Oct 1;128(10):4329-4342
pubmed: 30047927
J Lipid Res. 2018 Jul;59(7):1084-1093
pubmed: 29627764